| # | Drug | Count |
|---|---|---|
| 0 | CAPECITABINE | 526 |
| 1 | METHOTREXATE SODIUM | 453 |
| 2 | OXALIPLATIN | 447 |
| 3 | FLUOROURACIL | 427 |
| 4 | FLUOROURACIL CREAM, 0.5% | 427 |
| 5 | METHOTREXATE | 402 |
| 6 | PREDNISONE | 391 |
| 7 | CISPLATIN | 387 |
| 8 | CARBOPLATIN | 385 |
| 9 | CYCLOPHOSPHAMIDE | 381 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTIBACTERIAL HAND WIPES | 107 | 0.3204 |
| 1 | BORIC ACID | 106 | 0.2986 |
| 2 | BENZALKONIUM CHLORIDE 0.13% | 107 | 0.2846 |
| 3 | BENZALKONIUM CHLORIDE | 107 | 0.2437 |
| 4 | EPIDERMAL GROWTH FACTOR | 1 | 0.1667 |
| 5 | OXYGEN GAS | 1 | 0.1111 |
| 6 | GENTIAN VIOLET | 2 | 0.0385 |
| 7 | DENOSUMAB-BMWO | 1 | 0.0303 |
| 8 | NALMEFENE HYDROCHLORIDE | 1 | 0.0233 |
| 9 | TRASTUZUMAB-DKST | 6 | 0.0219 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 1102 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 1075 |
| 2 | Corticosteroid [EPC] | 841 |
| 3 | Alkylating Drug [EPC] | 562 |
| 4 | Kinase Inhibitor [EPC] | 531 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 479 |
| 6 | Microtubule Inhibitor [EPC] | 422 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 371 |
| 8 | Proteasome Inhibitor [EPC] | 331 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 319 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 10 | 0.0092 |
| 1 | Gamma Secretase Inhibitor [EPC] | 8 | 0.0087 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 42 | 0.0072 |
| 3 | Actinomycin [EPC] | 15 | 0.0068 |
| 4 | alpha-1 Adrenergic Agonist [EPC] | 22 | 0.0050 |
| 5 | Human Immunoglobulin G [EPC] | 90 | 0.0043 |
| 6 | Platinum-based Drug [EPC] | 1102 | 0.0040 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 1075 | 0.0039 |
| 8 | CD22-directed Immunoconjugate [EPC] | 11 | 0.0037 |
| 9 | Histone Deacetylase Inhibitor [EPC] | 13 | 0.0034 |